286 related articles for article (PubMed ID: 30293453)
1. Pancreatic islet dysfunction in type 2 diabetes mellitus.
Hu F; Qiu X; Bu S
Arch Physiol Biochem; 2020 Jul; 126(3):235-241. PubMed ID: 30293453
[TBL] [Abstract][Full Text] [Related]
2. Islet dysfunction in non-insulin-dependent diabetes mellitus.
Kahn SE; Porte D
Am J Med; 1988 Nov; 85(5A):4-8. PubMed ID: 3057894
[TBL] [Abstract][Full Text] [Related]
3. The Potential Causes of Cystic Fibrosis-Related Diabetes.
Coderre L; Debieche L; Plourde J; Rabasa-Lhoret R; Lesage S
Front Endocrinol (Lausanne); 2021; 12():702823. PubMed ID: 34394004
[TBL] [Abstract][Full Text] [Related]
4. Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes.
Malik SS; Padmanabhan D; Hull-Meichle RL
Front Endocrinol (Lausanne); 2023; 14():1269139. PubMed ID: 38075070
[TBL] [Abstract][Full Text] [Related]
5. Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat.
Tokuyama Y; Sturis J; DePaoli AM; Takeda J; Stoffel M; Tang J; Sun X; Polonsky KS; Bell GI
Diabetes; 1995 Dec; 44(12):1447-57. PubMed ID: 7589853
[TBL] [Abstract][Full Text] [Related]
6. Islet neuronal abnormalities associated with impaired insulin secretion in type 2 diabetes in the Chinese hamster.
Kohnert KD; Axcrona UM; Hehmke B; Klöting I; Sundler F; Ahrén B
Regul Pept; 1999 Jun; 82(1-3):71-9. PubMed ID: 10458649
[TBL] [Abstract][Full Text] [Related]
7. Understanding childhood diabetes mellitus: new pathophysiological aspects.
Grulich-Henn J; Klose D
J Inherit Metab Dis; 2018 Jan; 41(1):19-27. PubMed ID: 29247329
[TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis-related diabetes is caused by islet loss and inflammation.
Hart NJ; Aramandla R; Poffenberger G; Fayolle C; Thames AH; Bautista A; Spigelman AF; Babon JAB; DeNicola ME; Dadi PK; Bush WS; Balamurugan AN; Brissova M; Dai C; Prasad N; Bottino R; Jacobson DA; Drumm ML; Kent SC; MacDonald PE; Powers AC
JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669939
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic pathology in non-insulin dependent diabetes (NIDDM).
Clark A; de Koning EJ; Hattersley AT; Hansen BC; Yajnik CS; Poulton J
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S39-47. PubMed ID: 8529518
[TBL] [Abstract][Full Text] [Related]
11. Islet amyloid polypeptide and type 2 diabetes.
Marzban L; Park K; Verchere CB
Exp Gerontol; 2003 Apr; 38(4):347-51. PubMed ID: 12670620
[TBL] [Abstract][Full Text] [Related]
12. The ΔF508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Is Associated With Progressive Insulin Resistance and Decreased Functional β-Cell Mass in Mice.
Fontés G; Ghislain J; Benterki I; Zarrouki B; Trudel D; Berthiaume Y; Poitout V
Diabetes; 2015 Dec; 64(12):4112-22. PubMed ID: 26283735
[TBL] [Abstract][Full Text] [Related]
13. Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury.
Stalvey MS; Muller C; Schatz DA; Wasserfall CH; Campbell-Thompson ML; Theriaque DW; Flotte TR; Atkinson MA
Diabetes; 2006 Jul; 55(7):1939-45. PubMed ID: 16804061
[TBL] [Abstract][Full Text] [Related]
14. Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets.
Ohsawa H; Kanatsuka A; Yamaguchi T; Makino H; Yoshida S
Biochem Biophys Res Commun; 1989 Apr; 160(2):961-7. PubMed ID: 2655598
[TBL] [Abstract][Full Text] [Related]
15. Expression and localization of cystic fibrosis transmembrane conductance regulator in the rat endocrine pancreas.
Boom A; Lybaert P; Pollet JF; Jacobs P; Jijakli H; Golstein PE; Sener A; Malaisse WJ; Beauwens R
Endocrine; 2007 Oct; 32(2):197-205. PubMed ID: 18040894
[TBL] [Abstract][Full Text] [Related]
16. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L
Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779
[TBL] [Abstract][Full Text] [Related]
17. High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction.
Kooptiwut S; Kebede M; Zraika S; Visinoni S; Aston-Mourney K; Favaloro J; Tikellis C; Thomas MC; Forbes JM; Cooper ME; Dunlop M; Proietto J; Andrikopoulos S
J Mol Endocrinol; 2005 Aug; 35(1):39-48. PubMed ID: 16087720
[TBL] [Abstract][Full Text] [Related]
18. Banting lecture 1990. Beta-cells in type II diabetes mellitus.
Porte D
Diabetes; 1991 Feb; 40(2):166-80. PubMed ID: 1991568
[TBL] [Abstract][Full Text] [Related]
19. Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets.
Olivier AK; Yi Y; Sun X; Sui H; Liang B; Hu S; Xie W; Fisher JT; Keiser NW; Lei D; Zhou W; Yan Z; Li G; Evans TI; Meyerholz DK; Wang K; Stewart ZA; Norris AW; Engelhardt JF
J Clin Invest; 2012 Oct; 122(10):3755-68. PubMed ID: 22996690
[TBL] [Abstract][Full Text] [Related]
20. CFTR Influences Beta Cell Function and Insulin Secretion Through Non-Cell Autonomous Exocrine-Derived Factors.
Sun X; Yi Y; Xie W; Liang B; Winter MC; He N; Liu X; Luo M; Yang Y; Ode KL; Uc A; Norris AW; Engelhardt JF
Endocrinology; 2017 Oct; 158(10):3325-3338. PubMed ID: 28977592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
